STAT

OCTOBER 17, 2024

Jazmin Evans was waiting on dialysis for four years before finally, on the Fourth of July last year, she received a kidney transplant. “Now I say the fireworks are for me,” said Evans, who was diagnosed with kidney disease when she was 17.  She would have been waiting even longer had it not been for a shift, in 2021, in the way that physicians calculate kidney function for Black patients like her.

286

286

PharmaVoice

OCTOBER 15, 2024

A Nobel Prize in chemistry for Google’s DeepMind protein-structure mapping is the tip of the iceberg for advances in drug discovery and development.

Drug Development 277

Drug Development 277

STAT

OCTOBER 16, 2024

If you’re aware of the H5N1 bird flu outbreak in U.S. dairy cattle — you may have seen some headlines or read something on social media — perhaps you are wondering what the fuss is about. Yes, there have been nearly a couple dozen human cases, but all have had mild symptoms. The virus does not decimate herds in the way it does poultry flocks; most — though not all — of the infected cows come through the illness OK.

363

363

pharmaphorum

OCTOBER 14, 2024

Eli Lilly may invest $364m in the UK and work with the government to tackle serious public health challenges including obesity.

145

145

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Guardian - Pharmaceutical Industry

OCTOBER 16, 2024

Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners The pharmaceutical company behind injectable weight-loss drugs has been accused of prioritising profits over the health of people in developing countries by halting production of its insulin pens. People living with type 1 diabetes who are reliant on the human insulin produced by Novo Nordisk, will instead be given glass vials and syringes – which they say are inconvenient

Diabetes 111

Diabetes Pharmaceutical Companies Pharmaceutical Companies 111

BioPharma Dive

OCTOBER 17, 2024

Vyalev’s clearance is the second victory for AbbVie in Parkinson’s this year, following an April readout for a drug acquired through its Cerevel buyout.

108

108

PharmaVoice

OCTOBER 14, 2024

Digital therapeutics have languished in the background of traditional medicines for years, but a recent reimbursement push may have gotten the ball rolling.

162

162

pharmaphorum

OCTOBER 15, 2024

Neuroscience specialist Lundbeck has agreed to buy Longboard Pharmaceuticals for $2.6 billion, expanding its pipeline with an epilepsy drug tipped as a future blockbuster.The Danish drugmaker has offered $60 per share for California biotech Longboard, with the main asset in the deal bexicaserin, an oral, centrally acting serotonin 5-HT 2C receptor super-agonist in late-stage testing for seizures associated with rare forms of epilepsy.

104

104

The Pharmacist

OCTOBER 10, 2024

The clinical pathways delivered under Pharmacy First are a 'good starting point' to define the scope of practice for Physician Associates (PAs), the Royal College of GPs (RCGP) has said. Pharmacists must undertake additional training to deliver minor ailments consultations under Pharmacy First. But the RCGP suggested that 'first point of contact presentations' of over […] The post Pharmacy First 'good starting point' for PA scope of practice, says RCGP appeared first on The Pharm

118

118

BioPharma Dive

OCTOBER 14, 2024

The deal would hand Lundbeck a treatment for a series of rare brain disorders that could, by the company's estimates, become a blockbuster product.

Drug Development 117

Drug Development 117

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

STAT

OCTOBER 15, 2024

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up  to get it in your inbox every Monday. Hello, you spry bunch. We’re coming to you on a Tuesday after yesterday’s holiday. What are you looking to read more about as the year winds down? Let us know: bob.herman@statnews.com.

Drug Development 359

Drug Development 359

Express Pharma

OCTOBER 14, 2024

Indian Council of Medical ResearchZydus Lifesciences has formalised a Memorandum of Agreement (MoA) with the Indian Council of Medical Research (ICMR) to initiate Phase 2 clinical trials of Desidustat in patients with Sickle Cell Disease. This Phase IIa, double-blind, randomised, placebo-controlled, parallel, multi-centre, proof-ofconcept study, co-funded and co-monitored by INTENT, Indian National Clinical Trial and Education Network, Clinical Studies and Trial Unit, Division of Development R

105

105

pharmaphorum

OCTOBER 15, 2024

GSK has filed lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and RSV

Vaccines 116

Vaccines 116

The Pharmacist

OCTOBER 15, 2024

Community pharmacy leaders shared their vision for the future of community pharmacy at the Pharmacy Show in Birmingham yesterday. Several leaders spoke about the need for adequate funding for the sector, the importance of upskilling, and the potential for pharmacies to do much more in terms of long-terms conditions management and prevention. Meeting local community […] The post Leaders cast their vision for the future of community pharmacy appeared first on The Pharmacist.

Community Pharmacies 106

Community Pharmacies Diabetes Vaccines 106

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

BioPharma Dive

OCTOBER 11, 2024

The French pharmaceutical giant said it’s in negotiations to sell a controlling stake of Opella to the private equity firm CD&R, in a deal that reportedly could be worth more than $16 billion.

111

111

STAT

OCTOBER 15, 2024

It was a dramatic call to action by the American Heart Association: The organization declared its decade-long goal culminating in 2020 was to slash deaths from cardiovascular disease and stroke by 20%. It also promised in its scientific journal to move all Americans toward “ideal cardiovascular health.” That never happened. Deaths did decrease by 15% from 2010, but it was a “disappointment” that fatalities linked to conditions like high blood pressure, heart failure,

356

356

Express Pharma

OCTOBER 14, 2024

Jagat Prakash Nadda, Union Minister of Health and Family Welfare inaugurated the 19th International Conference of Drug Regulatory Authorities (ICDRA). The event is being hosted in India for the first time, from October 14-18, 2024 by the Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare, in collaboration with the World Health Organization (WHO) brings together regulatory authorities, policymakers, and health officials from over 194 WHO member states.

Vaccines 105

Vaccines Generic Medicine Hospitals 105

pharmaphorum

OCTOBER 14, 2024

Damage to a Baxter manufacturing facility caused by Hurricane Helene, which rolled across the east US a couple of weeks ago, has led to shortages in some critical medicines.The plant in North Cove, North Carolina, was severely affected by flooding and had to be shut down at the end of September. It is Baxter's biggest manufacturing site and is also the largest supplier of intravenous and peritoneal dialysis solutions to the US market.

108

108

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

The Pharmacist

OCTOBER 11, 2024

A pharmacist has given a first-hand account of the difficult experiences he and pharmacy teams faced during the Covid-19 pandemic, as part of an independent inquiry into the UK’s response to the outbreak. From major issues with ordering and storing stock, working night shifts to keep up with demands, and sourcing their own personal protective […] The post Covid inquiry: Pharmacist lays bare difficulties faced by sector appeared first on The Pharmacist.

112

112

BioPharma Dive

OCTOBER 10, 2024

In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.

112

112

STAT

OCTOBER 14, 2024

It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age.  An observational study published Monday in JAMA Network Open found that children and adolescents were one-and-a-half times more likely to be diagnosed with the metabolic disorder in the months after having Covid-19 compared to similar kids who weathered other respiratory infections.

Diabetes 363

Diabetes Hospitals 363

Express Pharma

OCTOBER 14, 2024

Accord BioPharma, the US specialty division of Intas Pharmaceuticals, focused on the development of oncology, immunology, and critical care therapies, announced that the USFDA has approved IMULDOSA (ustekinumab-srlf), a biosimilar to STELARA (ustekinumab), for the treatment of chronic inflammatory conditions, including psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.

Biosimilars 105

Biosimilars 105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

OCTOBER 11, 2024

Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially.The French pharma group confirmed this morning that it has entered into talks with US-based Clayton Dubilier & Rice to sell a controlling 50% stake in the unit for what has been estimated by Reuters to be in the region of €15 billion ($16.4 billion).

105

105

The Pharmacist

OCTOBER 10, 2024

Concern has been raised over what have been described as 'incorrect and misleading' figures released today by the NHS Business Services Authority (NHSBSA) which suggest a record number of active dispensing contractors in several years. New data published by the NHSBSA claim that 2023/24 saw the 'highest number of active dispensing contractors since 2015/16'.

112

112

Pharmaceutical Technology

OCTOBER 14, 2024

Trends in gene therapy approvals in recent years are rapidly shaping the future of manufacturing capabilities in the pharmaceutical industry.

110

110

STAT

OCTOBER 14, 2024

When the U.S. health care system pivoted to meet Covid-19 in 2020, routine health visits and screenings where many cancer cases would have been caught didn’t happen. It wasn’t ideal, but many health experts thought that as the country opened back up, screenings would help “catch up” to these missed cases. A new paper published Monday in JAMA Network Open suggests that didn’t happen as quickly as experts had hoped.

363

363

Express Pharma

OCTOBER 10, 2024

Aerogen, a global leader in acute-care aerosol drug delivery based in Ireland, and the Indian Association of Respiratory Care (IARC) have signed a Memorandum of Understanding (MoU) to advance respiratory therapy education and improve patient care throughout India. This collaboration focuses on elevating respiratory services and outcomes across the country.

Hospitals 105

Hospitals 105

pharmaphorum

OCTOBER 14, 2024

Revitalising life sciences hiring through creative recruitment strategies can make a significant impact on R&D, manufacturing, and medtech industries. Learn more about how innovative hiring practices can enhance talent acquisition in the life sciences sector.

97

97

The Pharmacist

OCTOBER 10, 2024

A commissioned 'repeat prescription review' service in community pharmacy should be explored to improve medicines adherence and patient understanding, the Royal Pharmaceutical Society (RPS) and Royal College of GPs (RCGP) have suggested. The recommendation comes as part of a new repeat prescribing toolkit, in what is believed to be the first guidance of its kind […] The post Community pharmacy repeat prescription review service ‘should be explored’ appeared first on The Pharmacist.

Community Pharmacies 107

Community Pharmacies 107

BioPharma Dive

OCTOBER 14, 2024

The approval of Hympavzi Friday was a dose of good news for Pfizer, which is dealing with research setbacks and a challenge from an activist investor.

104

104

STAT

OCTOBER 14, 2024

Biotech investors have been buzzing around new areas of drug development this year, such as the red-hot obesity market. But there’s one field that has seen an even more significant amount of activity: autoimmune diseases. Companies that are developing new medicines for autoimmune conditions, as well as other immune system disorders, have brought in more money and closed more deals so far this year than most other areas, including the cardiometabolic field, data from investment bank Oppenh

Immunization 363

Immunization Immunity Drug Development 363

Express Pharma

OCTOBER 11, 2024

The Food Safety and Standards Authority of India (FSSAI) uncovered a rather disturbing trend last year. A nationwide enforcement drive revealed that over 15 per cent of tested health supplement samples failed to meet regulatory standards. This revelation highlights the growing pains of a sector that promises health benefits to millions of consumers.

Labelling 105

Labelling Diabetes Immunization Immunity 105